Search

everythinglearnresearchcommunity

for

Search:↓

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

PRP shows promise for treating hair loss but needs more research.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

A small percentage of minoxidil users may develop an allergic skin reaction.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Men with early-onset hair loss have more heart disease risk factors.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.